Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Sep 16, 2015 at 11:05 AM EDT

Meet the Newest Biotech Collaboration: Amgen and Xencor

Amgen and Xencor have entered into a research and license agreement to develop and commercialize novel therapeutics in the areas…

Chris Lange | Sep 16, 2015 at 10:05 AM EDT

Intra-Cellular Shares Continue to Climb on Positive Results

Intra-Cellular Therapies announced positive results from the first Phase 3 clinical trial of ITI-007 for the treatment of patients with…

Chris Lange | Sep 15, 2015 at 3:26 PM EDT

Penumbra and RegenXBio Gearing Up for IPOs

ThinkstockTwo private companies in the healthcare sector, Penumbra Inc. and RegenXBio Inc., are planning on going public in later this…

Chris Lange | Sep 15, 2015 at 11:40 AM EDT

Solid Draft Guidance Propels Evoke

Shares of Evoke Pharma rose in the market on Tuesday in the wake of solid draft guidance for its Phase…

Chris Lange | Sep 15, 2015 at 10:40 AM EDT

Sientra Updates Terms for Secondary Offering

Sientra has filed with the U.S. Securities and Exchange Commission (SEC) to update the terms for its secondary offering.

Chris Lange | Sep 15, 2015 at 9:55 AM EDT

How GW Pharma’s Newest Cannabinoid Trial Is a Game Changer

GW Pharmaceuticals is making great strides in the field of medicine with its most recent trial of Cannabidiol in patients…

Chris Lange | Sep 15, 2015 at 8:40 AM EDT

Xenoport Rises on Solid Phase 2 Results

Xenoport made waves in Tuesday morning’s premarket trading session on news of positive clinical trial results.

Chris Lange | Sep 14, 2015 at 10:25 AM EDT

Dimension Therapeutics Gears Up for IPO

Dimension Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).

Chris Lange | Sep 14, 2015 at 9:05 AM EDT

Is Raptor Pharma Imploding?

Raptor Pharmaceuticals saw its shares approach its 52-week low in Monday's premarket, after missed results in a Phase 2 study.

Chris Lange | Sep 12, 2015 at 9:25 AM EDT

This Past Week’s Top 5 Biotech Movers

Over the past week, a few biotech companies made absolutely massive runs with at least 25% gains.

Chris Lange | Sep 11, 2015 at 2:05 PM EDT

Arrowhead Rises on Positive Candidate News

Arrowhead Research made waves in the market on Friday afternoon on positive developments surrounding its ARC-HIF2.

Chris Lange | Sep 11, 2015 at 8:25 AM EDT

Short Sellers Become More Selective in Major Pharma

The short interest data have been released for the August 31 settlement date, and for the selected pharmaceutical stocks, short…

Lee Jackson | Sep 11, 2015 at 8:20 AM EDT

Jefferies Starts Coverage on Biotechs: 3 Top Stocks to Buy Now

In a new and very comprehensive report, Jefferies starts coverage on biotechs with some very targeted stock selections.

Chris Lange | Sep 11, 2015 at 8:05 AM EDT

Short Sellers Increase Bets in Major Biotechs

The short interest data are out for the August 31 settlement date. Short interest in the selected biotech stocks increased…

Chris Lange | Sep 10, 2015 at 4:18 PM EDT

AbbVie Posts Another Win for Humira

ThinkstockAbbVie Inc. (NYSE: ABBV) has continued to push forward over the past year and shares are actually up 7.3% in…

1 … 245 246 247 248 249 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Meet the Newest Biotech Collaboration: Amgen and Xencor

Intra-Cellular Shares Continue to Climb on Positive Results

Penumbra and RegenXBio Gearing Up for IPOs

Solid Draft Guidance Propels Evoke

Sientra Updates Terms for Secondary Offering

How GW Pharma’s Newest Cannabinoid Trial Is a Game Changer

Xenoport Rises on Solid Phase 2 Results

Dimension Therapeutics Gears Up for IPO

Is Raptor Pharma Imploding?

This Past Week’s Top 5 Biotech Movers

Arrowhead Rises on Positive Candidate News

Short Sellers Become More Selective in Major Pharma

Jefferies Starts Coverage on Biotechs: 3 Top Stocks to Buy Now

Short Sellers Increase Bets in Major Biotechs

AbbVie Posts Another Win for Humira

The Reverse Mortgage Line of Credit That Grows Untouched for 15 Years and Becomes a $700,000 Liquidity Buffer at 80

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how

The Reverse Mortgage Line of Credit That Grows Untouched for 15 Years and Becomes a $700,000 Liquidity Buffer at 80

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Health and Healthcare Articles

All Health and Healthcare Articles

Meet the Newest Biotech Collaboration: Amgen and Xencor

Intra-Cellular Shares Continue to Climb on Positive Results

Penumbra and RegenXBio Gearing Up for IPOs

Solid Draft Guidance Propels Evoke

Sientra Updates Terms for Secondary Offering

How GW Pharma’s Newest Cannabinoid Trial Is a Game Changer

Xenoport Rises on Solid Phase 2 Results

Dimension Therapeutics Gears Up for IPO

Is Raptor Pharma Imploding?

This Past Week’s Top 5 Biotech Movers

Arrowhead Rises on Positive Candidate News

Short Sellers Become More Selective in Major Pharma

Jefferies Starts Coverage on Biotechs: 3 Top Stocks to Buy Now

Short Sellers Increase Bets in Major Biotechs

AbbVie Posts Another Win for Humira

The Reverse Mortgage Line of Credit That Grows Untouched for 15 Years and Becomes a $700,000 Liquidity Buffer at 80

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Featured Reads

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how